In addition, analysis of the transcriptional profiles of 1097 breast tumors collected from The Cancer Genome Atlas (TCGA) revealed that the expression of GABARAPL1 was substantially lower than that in normal breast tissues (Fig. S4), indicative of an essential role of GABARAPL1 downregulation during breast cancer progression. Here, GABARAPL1 is linked to breast carcinoma.